LIGAND PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Ligand Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 18M shares, a 4.35% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.3M shares, a 2.55% increase from 2022.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16.9M shares, a 1.43% increase from 2021.
  • Ligand Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 16.6M shares, a 2.75% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 18M +752K +4.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 17.7M +669K +3.92% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 17.3M +408K +2.42% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 17.4M +492K +2.91% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 17.3M +408K +2.42% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 17.1M +239K +1.42% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 16.9M +157K +0.94% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 16.9M +200K +1.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 16.9M +209K +1.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 16.8M +389K +2.37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 16.7M +656K +4.08% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 16.7M +606K +3.77% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-28
Q2 2021 16.7M +604K +3.76% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-28
Q1 2021 16.4M -94K -0.57% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-28
Q4 2020 16.1M -1.17M -6.76% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 16.1M -2.69M -14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 16.1M -3.5M -17.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 16.5M -3.92M -19.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 17.2M -3.83M -18.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 18.8M -2.38M -11.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 19.6M -1.65M -7.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 20.4M -762K -3.59% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 21.1M 0 0% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 21.1M 0 0% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 21.2M 0 0% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 21.2M 0 0% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 21.1M +173K +0.83% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 21.1M +261K +1.25% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 21.2M +380K +1.82% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 21.2M +501K +2.42% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 20.9M +965K +4.84% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 20.9M +1M +5.03% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 20.8M +1.11M +5.61% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 20.7M +1.1M +5.59% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 19.9M +55K +0.28% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 19.9M -530K -2.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 19.7M -1.01M -4.89% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 19.6M -989K -4.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 19.9M -565K -2.76% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-11-15
Q3 2014 20.4M +59.4K +0.29% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-11-15
Q2 2014 20.7M +479K +2.37% Apr 1, 2014 Jun 30, 2014 10-K/A 2016-11-15
Q1 2014 20.6M +412K +2.04% Jan 1, 2014 Mar 31, 2014 10-K/A 2016-11-15
Q4 2013 20.4M +408K +2.04% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-23
Q3 2013 20.4M +440K +2.21% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-23
Q2 2013 20.3M +509K +2.58% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-23
Q1 2013 20.2M +480K +2.44% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-23
Q4 2012 20M +360K +1.83% Oct 1, 2012 Dec 31, 2012 10-K/A 2014-12-12
Q3 2012 19.9M +245K +1.24% Jul 1, 2012 Sep 30, 2012 10-K/A 2014-12-12
Q2 2012 19.7M +99.3K +0.51% Apr 1, 2012 Jun 30, 2012 10-K/A 2014-12-12
Q1 2012 19.7M +86.1K +0.44% Jan 1, 2012 Mar 31, 2012 10-K/A 2014-12-12
Q4 2011 19.7M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 19.7M +43.3K +0.22% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 19.7M +41.3K +0.21% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 19.6M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 19.6M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-10
Q2 2010 19.6M Apr 1, 2010 Jun 30, 2010 10-Q/A 2012-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.